Adial Pharmaceuticals
$2.88
65
-$0.10-3.36% Today
Statistics
Day High
3.12
Day Low
2.7
52W High
19
52W Low
1.31
Volume
10,255,558
Avg. Volume
-
Mkt Cap
69.09M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19AugExpected
Expected EPS
-1.065
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-26.39MNet Income
Analyst Ratings
6.00Average Price Target
The highest estimate is 6.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ADIL. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Alkermes
ALKS
Mkt Cap7.08B
Indivior Pharmaceuticals
INDV
Mkt Cap4.45B
Opko Health
OPK
Mkt Cap1.07B
Acadia Pharmaceuticals
ACAD
Mkt Cap3.61B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.81B
Jazz Pharmaceuticals
JAZZ
Mkt Cap14.48B
Supernus Pharmaceuticals
SUPN
Mkt Cap2.58B
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.32B
Vertex Pharmaceuticals
VRTX
Mkt Cap112.92B
About
Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of alcohol use disorder. Beyond this flagship product, the company is also exploring drug candidates aimed at providing non-opioid pain relief and addressing a range of other medical conditions. Established in 2010, Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia.
Show more...
CEO
Mr. Cary John Claiborne MBA
Employees
5
Country
United States
ISIN
US00688A3041
Listings
0 Comments
Share your thoughts
FAQ
What is Adial Pharmaceuticals stock price today?▼
The current price of ADIL is $2.88 USD — it has decreased by -3.36% in the past 24 hours. Watch Adial Pharmaceuticals stock price performance more closely on the chart.
What is Adial Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Adial Pharmaceuticals stocks are traded under the ticker ADIL.
Is Adial Pharmaceuticals stock price growing?▼
ADIL stock has risen by +29.41% compared to the previous week, the month change is a +107.25% rise, over the last year Adial Pharmaceuticals has showed a -67.32% decrease.
What is Adial Pharmaceuticals market cap?▼
Today Adial Pharmaceuticals has the market capitalization of 69.09M
When is the next Adial Pharmaceuticals earnings date?▼
Adial Pharmaceuticals is going to release the next earnings report on August 19, 2026.
What were Adial Pharmaceuticals earnings last quarter?▼
ADIL earnings for the last quarter are -1.48 USD per share, whereas the estimation was -2.73 USD resulting in a +45.79% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Adial Pharmaceuticals revenue for the last year?▼
Adial Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Adial Pharmaceuticals net income for the last year?▼
ADIL net income for the last year is -26.39M USD.
How many employees does Adial Pharmaceuticals have?▼
As of June 15, 2026, the company has 5 employees.
In which sector is Adial Pharmaceuticals located?▼
Adial Pharmaceuticals operates in the Health & Wellness sector.
When did Adial Pharmaceuticals complete a stock split?▼
The last stock split for Adial Pharmaceuticals was on February 06, 2026 with a ratio of 1:25.
Where is Adial Pharmaceuticals headquartered?▼
Adial Pharmaceuticals is headquartered in Glen Allen, United States.